News
07-18-2011, 04:00 AM
The use of trastuzumab, chemotherapy and surgery among women with HER2-positive metastatic breast cancer significantly improved survival from the time central nervous system metastases were diagnosed.
More... (http://www.news-medical.net/news/20110718/HER2-positive-metastatic-breast-cancer-women-benefit-from-trastuzumab-and-chemotherapy.aspx)
More... (http://www.news-medical.net/news/20110718/HER2-positive-metastatic-breast-cancer-women-benefit-from-trastuzumab-and-chemotherapy.aspx)